BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 25180601)

  • 1. Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature.
    Shen J; Frye M; Lee BL; Reinardy JL; McClung JM; Ding K; Kojima M; Xia H; Seidel C; Lima e Silva R; Dong A; Hackett SF; Wang J; Howard BW; Vestweber D; Kontos CD; Peters KG; Campochiaro PA
    J Clin Invest; 2014 Oct; 124(10):4564-76. PubMed ID: 25180601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema.
    Campochiaro PA; Peters KG
    Curr Diab Rep; 2016 Dec; 16(12):126. PubMed ID: 27778249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Small Molecule Inhibitor of VE-PTP Activates Tie2 in Schlemm's Canal Increasing Outflow Facility and Reducing Intraocular Pressure.
    Li G; Nottebaum AF; Brigell M; Navarro ID; Ipe U; Mishra S; Gomez-Caraballo M; Schmitt H; Soldo B; Pakola S; Withers B; Peters KG; Vestweber D; Stamer WD
    Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):12. PubMed ID: 33315051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular Endothelial Receptor Tyrosine Phosphatase: Identification of Novel Substrates Related to Junctions and a Ternary Complex with EPHB4 and TIE2.
    Drexler HCA; Vockel M; Polaschegg C; Frye M; Peters K; Vestweber D
    Mol Cell Proteomics; 2019 Oct; 18(10):2058-2077. PubMed ID: 31427368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Angiopoietin-Tie2 Signaling Protects the Kidney from Ischemic Injury by Modulation of Endothelial-Specific Pathways.
    Li Y; Liu P; Zhou Y; Maekawa H; Silva JB; Ansari MJ; Boubes K; Alia Y; Deb DK; Thomson BR; Jin J; Quaggin SE
    J Am Soc Nephrol; 2023 Jun; 34(6):969-987. PubMed ID: 36787763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interfering with VE-PTP stabilizes endothelial junctions in vivo via Tie-2 in the absence of VE-cadherin.
    Frye M; Dierkes M; Küppers V; Vockel M; Tomm J; Zeuschner D; Rossaint J; Zarbock A; Koh GY; Peters K; Nottebaum AF; Vestweber D
    J Exp Med; 2015 Dec; 212(13):2267-87. PubMed ID: 26642851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis of retinal and choroidal vascular diseases.
    Campochiaro PA
    Prog Retin Eye Res; 2015 Nov; 49():67-81. PubMed ID: 26113211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VE-PTP inhibition elicits eNOS phosphorylation to blunt endothelial dysfunction and hypertension in diabetes.
    Siragusa M; Oliveira Justo AF; Malacarne PF; Strano A; Buch A; Withers B; Peters KG; Fleming I
    Cardiovasc Res; 2021 May; 117(6):1546-1556. PubMed ID: 32653904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The VE-PTP Inhibitor AKB-9778 Improves Antitumor Activity and Diminishes the Toxicity of Interleukin 2 (IL-2) Administration.
    Li G; Sachdev U; Peters K; Liang X; Lotze MT
    J Immunother; 2019 Sep; 42(7):237-243. PubMed ID: 31348125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopoietin-2-induced blood-brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling.
    Gurnik S; Devraj K; Macas J; Yamaji M; Starke J; Scholz A; Sommer K; Di Tacchio M; Vutukuri R; Beck H; Mittelbronn M; Foerch C; Pfeilschifter W; Liebner S; Peters KG; Plate KH; Reiss Y
    Acta Neuropathol; 2016 May; 131(5):753-73. PubMed ID: 26932603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of diabetic macular edema with an inhibitor of vascular endothelial-protein tyrosine phosphatase that activates Tie2.
    Campochiaro PA; Sophie R; Tolentino M; Miller DM; Browning D; Boyer DS; Heier JS; Gambino L; Withers B; Brigell M; Peters K
    Ophthalmology; 2015 Mar; 122(3):545-54. PubMed ID: 25439435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shear stress control of vascular leaks and atheromas through Tie2 activation by VE-PTP sequestration.
    Shirakura K; Baluk P; Nottebaum AF; Ipe U; Peters KG; McDonald DM; Vestweber D
    EMBO Mol Med; 2023 Apr; 15(4):e16128. PubMed ID: 36740996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Ocular Vascular Inflammation through Peptide-Mediated Activation of Angiopoietin-Tie2 Signaling.
    Mirando AC; Lima E Silva R; Chu Z; Campochiaro PA; Pandey NB; Popel AS
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A collagen IV-derived peptide disrupts α5β1 integrin and potentiates Ang2/Tie2 signaling.
    Mirando AC; Shen J; Silva RLE; Chu Z; Sass NC; Lorenc VE; Green JJ; Campochiaro PA; Popel AS; Pandey NB
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30668550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formation.
    Hayashi M; Majumdar A; Li X; Adler J; Sun Z; Vertuani S; Hellberg C; Mellberg S; Koch S; Dimberg A; Koh GY; Dejana E; Belting HG; Affolter M; Thurston G; Holmgren L; Vestweber D; Claesson-Welsh L
    Nat Commun; 2013; 4():1672. PubMed ID: 23575676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization.
    Takagi H; Koyama S; Seike H; Oh H; Otani A; Matsumura M; Honda Y
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):393-402. PubMed ID: 12506101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tie2 activation promotes choriocapillary regeneration for alleviating neovascular age-related macular degeneration.
    Kim J; Park JR; Choi J; Park I; Hwang Y; Bae H; Kim Y; Choi W; Yang JM; Han S; Chung TY; Kim P; Kubota Y; Augustin HG; Oh WY; Koh GY
    Sci Adv; 2019 Feb; 5(2):eaau6732. PubMed ID: 30788433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tie-2/Angiopoietin pathway modulation as a therapeutic strategy for retinal disease.
    Hussain RM; Neiweem AE; Kansara V; Harris A; Ciulla TA
    Expert Opin Investig Drugs; 2019 Oct; 28(10):861-869. PubMed ID: 31513439
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting VE-PTP phosphatase protects the kidney from diabetic injury.
    Carota IA; Kenig-Kozlovsky Y; Onay T; Scott R; Thomson BR; Souma T; Bartlett CS; Li Y; Procissi D; Ramirez V; Yamaguchi S; Tarjus A; Tanna CE; Li C; Eremina V; Vestweber D; Oladipupo SS; Breyer MD; Quaggin SE
    J Exp Med; 2019 Apr; 216(4):936-949. PubMed ID: 30886059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the effect of inhibitor AKB-9778 on VE-PTP by molecular docking and molecular dynamics simulation.
    Liu WS; Wang RR; Sun YZ; Li WY; Li HL; Liu CL; Ma Y; Wang RL
    J Cell Biochem; 2019 Oct; 120(10):17015-17029. PubMed ID: 31125141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.